Dividend-adjusted total return · S&P 500 uses VOO · Aug 6, 2026 – Nov 4, 2026ARKGS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +0.4% | −4.0% | +22.5% | +71.5% | +62.1% | +121.5% | −32.5% | +167.0% |
| Peer average | +2.7% | +8.5% | +8.9% | +24.4% | +33.4% | +84.3% | +34.0% | — |
| S&P 500 · VOO | +1.6% | −1.6% | 0.0% | +13.4% | +13.5% | +91.7% | +81.2% | — |
Key Statistics
Open all fund facts →- AUM
- $2.2B
- Expense ratio
- 0.75%
- Distribution yield
- 0.0%
- NAV
- $49.57
- Volume
- 4.2M
- Avg. volume 30D
- 5.7M
- High today
- $50.44
- Low today
- $47.67
- Previous close
- $49.51
- 52-week high
- $58.83
- 52-week low
- $24.60
- Our risk indicator
- 4/5
ARKG in One Breath
ARKG Among Health Care ETFs
YTDEnd-of-day Nov 5, 2026 · 33 Health care ETFs by YTD
$10,000 in ARKG
5Y$10,000 in ARKG became
$6,752
In the S&P 500 (VOO)
$18,115
Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO
ARKG’s Top Holdings
TodayTEMTempus Ai -9.5%TWST7.9%TXG7.8%CRSP5.3%GH5.1%ABSI5.1%NTRA4.7%LLY4.5%ILMN4.4%CDNA4.4%BEAM3.8%VCYT3.8%SDGR3.0%NRIX2.8%RXRX2.7%ADPT2.3%CMPS2.3%NTLA1.9%WGS1.8%IONS1.7%PRME1.7%ALMROther
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - Application
ARK ARKG · 10 holdings · tile size = share of the fund · as of Nov 4, 2026
What ARKG Holds
TodayBiotechnology50.1%
TWST 7.9 · TXG 7.8 · CRSP 5.3 · ABSI 5.1 · BEAM 3.8 · NRIX 2.8 · RXRX 2.7
Medical - Diagnostics & Research25.4%
GH 5.1 · NTRA 4.7 · ILMN 4.4 · CDNA 4.4 · VCYT 3.8 · WGS 1.8 · FRNM
Medical - Healthcare Information Services9.5%
TEM 9.5
Drug Manufacturers - General4.5%
LLY 4.5
Software - Application3.9%
SDGR 3.0 · IAM
Medical - Devices3.8%
BFLY 1.5 · PACB 1.4 · CERS
Medical - Specialties1.0%
MASS 1.0
ARK ARKG · share of the fund by industry · as of Nov 4, 2026
Tempus’ Share of ARKG
Today9.5%
$95 of every $1,000 in ARKG is Tempus
Tempus held by ARKG
$211M
ARK ARKG · each square = $10 of $1,000 · as of Nov 4, 2026
ARKG’s Share of Health Care ETFs
Today2.0%
of the $110B in 39 Health care ETFs
$2.2B2.0%
$49.1B44.7%
$19.1B17.4%
$39.4B35.8%
Health care ETF AUM · Nov 5, 2026
ARKG Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 5, 2026
Inside ARKG
10 holdings · as of Nov 4, 2026ARKG
ARK Genomic Revolution ETF
TodayBiotechnology50.1%TWST7.9%TXG7.8%CRSP5.3%ABSI5.1%BEAM3.8%NRIX2.8%RXRX2.7%ADPT2.3%CMPS2.3%NTLAIONSPRMEALMRARCT2 moreMedical - Diagnostics25.4%GH5.1%NTRA4.7%ILMN4.4%CDNA4.4%VCYT3.8%WGSFRNMMedical - Healthcare Information Services9.5%TEM9.5%Drug Manufacturers - General4.5%LLY4.5%Software - Application3.9%SDGR3.0%IAMMedical - Devices3.8%BFLYPACBCERSMASSOther1.8%SCTX
Biotechnology50.1%TWST7.9%TXG7.8%CRSP5.3%ABSI5.1%BEAMNRIX10 more holdings17.4% of the fundMedical - Diagnostics25.4%GH5.1%NTRA4.7%ILMN4.4%CDNA4.4%VCYT3.8%WGSMedical - Healthcare Information Services9.5%TEM9.5%Drug Manufacturers - General4.5%LLYSoftware - Application3.9%SDGRMedical - Devices3.8%BFLYPACBMASSSCTX
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TEM | Tempus AI - | 9.51% |
| 2 | TWST | Twist Bioscience | 7.86% |
| 3 | TXG | 10X Genomics - | 7.76% |
| 4 | CRSP | Crispr Therapeutics AG | 5.34% |
| 5 | GH | Guardant Health | 5.12% |
| 6 | ABSI | Absci | 5.10% |
| 7 | NTRA | Natera | 4.66% |
| 8 | LLY | ELI Lilly & | 4.47% |
| 9 | ILMN | Illumina | 4.44% |
| 10 | CDNA | Caredx | 4.39% |
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - ApplicationMedical - DevicesMedical - SpecialtiesOther
ARK ARKG · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 84.7%
How It Compares
ARKG
ARK Genomic Revolution ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM
Head to Head
Put ARKG head to head with XLV →XLV vs ARKG
YTDYear to date
ARKG wins+47.5 pts
Past year
ARKG wins+28.6 pts
Fee
XLV winslower fee
Yield
XLV wins+1.3 pts
AUM
XLV22.1× more
2–2level
SPDR XLV and ARK ARKG · year-to-date · as of Nov 5, 2026 · AUM not scored
ARKG vs VOO
YTDARKG · ARK Genomic Revolution
+71.5%
VOO · S&P 500
+13.4%
Gap
58.2 pts
ARK ARKG and Vanguard VOO · YTD total return · as of Nov 5, 2026
ARKG vs Its Peer Average
YTDARKGAvsBPeer average
1D+0.4%+2.7%
1M−4.0%+8.5%
3M+22.5%+8.9%
YTD+71.5%+24.4%
1Y+62.1%+33.4%
3Y+121.5%+84.3%
5Y−32.5%+34.0%
4–3ARKG wins
38 Health care peers · each row scaled to its leader
The Details
ARKG
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y45.78%
Deepest drop · 1Y−27.5%
Lowest point · 5Y−74.2%
52-week range
$49.69
$24.60−15.5% from the high$58.83
ARK ARKG · past-year price moves · as of Nov 5, 2026
ARKG
Fund Facts
Today2014launched Oct 31
Tracks[…]
Exchange · CUSIPCBOE · 00214Q302
StructureETF
Leverage1x
Cost on $10,000$75 a year
Go deeper
ARK ARKG · fund facts · as of Nov 5, 2026
ARKG
Payouts by Year
5Y$0.38per share, Dec 2021
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 29 · Dec 31, 2021
5 payouts added up$3.02 a share
ARK ARKG · distributions by ex-date · 2017–2021
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-07-31 ↗SEC reported portfolio · 2026-04-30 ↗SEC reported portfolio · 2026-01-30 ↗SEC reported portfolio · 2025-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-07-31 ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-07-31 ↗SEC reported portfolio · 2024-04-30 ↗SEC reported portfolio · 2024-01-31 ↗SEC reported portfolio · 2023-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-07-31 ↗SEC reported portfolio · 2023-04-28 ↗SEC reported portfolio · 2023-01-31 ↗SEC reported portfolio · 2022-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-07-29 ↗SEC reported portfolio · 2022-04-29 ↗SEC reported portfolio · 2022-01-31 ↗SEC reported portfolio · 2021-10-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-07-30 ↗SEC reported portfolio · 2021-04-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-01-29 ↗SEC reported portfolio · 2020-10-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-07-31 ↗SEC reported portfolio · 2020-04-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$49.57
Premium / discount[…]
Median spread · 30D[…]
Volume today4.2M
Average volume · 30D5.7M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.75%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$75.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 29, 2021 | Dec 31, 2021 | $0.38 |
| Dec 29, 2020 | Dec 31, 2020 | $0.79 |
| Dec 27, 2019 | Dec 31, 2019 | $1.05 |
| Dec 27, 2018 | Dec 31, 2018 | $0.47 |
| Dec 27, 2017 | Dec 29, 2017 | $0.33 |
Issuer contentFrom ARKHear the strategy from the people behind ARKG.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →